| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1367097 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
High throughput screening (HTS) led to the identification of the guanylhydrazone of 2-(4-chlorobenzyloxy)-5-bromobenzaldehyde as a CCR5 receptor antagonist. Modifications of the guanylhydrazone resulted in the discovery of novel CCR5 antagonists.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Robert G. Wei, Damian O. Arnaiz, Yuo-Ling Chou, Dave Davey, Laura Dunning, Wheeseong Lee, Shou-Fu Lu, James Onuffer, Bin Ye, Gary Phillips,